azilsartan vs telmisartan
Side-by-side comparison of azilsartan and telmisartan. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Edarbi
Micardis
No summary available.
Telmisartan (Micardis) is a medicine that lowers blood pressure. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs).
Information not available.
Telmisartan is used to treat high blood pressure. Lowering blood pressure reduces the risk of strokes and heart attacks. It can also lower cardiovascular risk if you cannot take ACE inhibitors. Controlling high blood pressure is important for overall heart health.
Information not available.
Telmisartan blocks a substance in your body that tightens blood vessels. This helps blood vessels relax and widens them. As a result, blood pressure is lowered.
- • Dizziness
- • Fatigue
- • Back pain
- • Sinus infection
- • Diarrhea
- • Upper respiratory tract infection
- • Sore throat
No adverse event reports.
- Feeling sick to your stomach 2,059
- Feeling tired 2,001
- Loose stools 1,794
- Difficulty breathing 1,783
- Head pain 1,715
No specific warnings noted.
If you are pregnant or plan to become pregnant, stop taking this medicine right away. Telmisartan can harm or cause death to your unborn baby.
No pregnancy information available.
Telmisartan can cause harm to your unborn baby, especially during the second and third trimesters. Do not breastfeed while taking telmisartan.
Also Compare, Nearby Drugs
Compare azilsartan with
Compare telmisartan with
How to Read This azilsartan vs telmisartan Comparison
azilsartan is classified in the Angiotensin II Receptor Blocker (ARB) drug class, while telmisartan sits within the Angiotensin II Receptor Blocker (ARB) class. Because both drugs share the same classification, they are often considered interchangeable in theory, but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, azilsartan has 0 submissions while telmisartan has 9,352. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between azilsartan and telmisartan - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.